This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Daftarian, M. P. Articles by Diaz-Mitoma, F. Search for Related Content PubMed PubMed Citation Articles by Daftarian, M. P. Articles by Diaz-Mitoma, F.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, Mar 1995, 199-204, Vol 2, No. 2
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Immune response to sulfamethoxazole in patients with AIDS

MP Daftarian, LG Filion, W Cameron, B Conway, R Roy, F Tropper and F Diaz-Mitoma
Department of Microbiology and Immunology, University of Ottawa, Ontario, Canada.

Antibody- and cell-mediated responses to sulfamethoxazole (SMX) were analyzed in AIDS patients with or without a history of hypersensitivity and in negative controls. In 20 of 20 (P < 0.01) human immunodeficiency virus (HIV)-seropositive patients with skin reactions to cotrimoxazole, we found SMX-specific antibodies, while only 9 of 20 and 17 of 20 HIV- seropositive patients without a history of hypersensitivity to cotrimoxazole had SMX-specific immunoglobulin M (IgM) and IgG, respectively. The levels of specific IgM and IgG were higher in patients with skin reactions than in patients without reactions (IgM, 1.0 +/- 0.19 versus 0.47 +/- 0.23 [P < 0.001]; IgG, 0.68 +/- 0.15 versus 0.47 +/- 0.14 [P < 0.001] [mean optical density values +/- standard deviations]). Seronegative controls with no history of exposure to sulfa compounds did not have SMX-specific IgG or IgM antibodies, and controls with a history of intake of SMX with or without reactions had low levels of IgG and IgM. The SMX-specific IgG subclasses were exclusively IgG1 and IgG3. None of the patients had detectable SMX-specific IgE or IgA antibodies nor did they exhibit a cell-mediated response as measured by a lymphocyte proliferation assay. Antibodies to SMX recognized N-acetyl-sulfonamide, N-(2-thiazolyl)- sulfanilamide, sulfadiazine, and sulfisoxazole but did not recognize sulfanilamide or 3-amino-5-methyl isoxazole in an inhibition assay. It is not known whether the SMX-specific antibodies associated with hypersensitivity reactions to SMX in HIV-seropositive patients have a pathogenic role in these reactions.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

• Manchanda, T., Hess, D., Dale, L., Ferguson, S. G., Rieder, M. J. (2002). Haptenation of Sulfonamide Reactive Metabolites to Cellular Proteins. Mol. Pharmacol. 62: 1011-1026 [Abstract] [Full Text]  
• Freund, Y. R., Dousman, L., MacGregor, J. T., Mohagheghpour, N. (2000). Oral Treatment with Trimethoprim-Sulfamethoxazole and Zidovudine Suppresses Murine Accessory Cell-Dependent Immune Responses. Toxicol Sci 55: 335-342 [Abstract] [Full Text]  
• Gill, H. J., Hough, S. J., Naisbitt, D. J., Maggs, J. L., Kitteringham, N. R., Pirmohamed, M., Park, B. K. (1997). The Relationship Between the Disposition and Immunogenicity of Sulfamethoxazole in the Rat. J. Pharmacol. Exp. Ther. 282: 795-801 [Abstract] [Full Text]